Gastroesophageal reflux and serum biomarkers in systemic sclerosis-associated interstitial lung disease: comment on the article by Elhai et al Reply

被引：0
|
作者：
Elhai, Muriel [1 ,2 ]
Hoffmann-Vold, Anna Maria [3 ,4 ]
Allanore, Yannick [1 ,2 ]
机构：
[1] Paris Descartes Univ, Cochin Inst, INSERM U1016, UMR8104, Paris, France
[2] Paris Descartes Univ, Cochin Hosp, Paris, France
[3] Oslo Univ Hosp, Oslo, Norway
[4] Univ Oslo, Inst Clin Med, Oslo, Norway
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷 / 07期
关键词：
D O I：
10.1002/art.40908
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1204 / 1206
页数：3
相关论文
共 50 条
  • [31] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [32] Progress in progressive pulmonary fibrosis: biomarkers of systemic sclerosis-associated interstitial lung disease
    Takada, Toshinori
    RHEUMATOLOGY, 2024, 63 (11) : 2907 - 2908
  • [33] Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    Chung, Jonathan H.
    Walker, Christopher M.
    Hobbs, Stephen
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (160): : na
  • [34] Personalized Medicine for Systemic Sclerosis-Associated Interstitial Lung Disease
    Ma, Angela
    Montesi, Sydney B.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2025, 11 (01)
  • [35] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Athanasios Koutroumpas
    Athanasios Ziogas
    Ioannis Alexiou
    Georgia Barouta
    Lazaros I. Sakkas
    Clinical Rheumatology, 2010, 29 : 1167 - 1168
  • [36] Clinical and methodologic considerations with regard to a trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: comment on the reanalysis by Maher et al
    Bredemeier, Markus
    ARTHRITIS & RHEUMATOLOGY, 2021,
  • [37] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Koutroumpas, Athanasios
    Ziogas, Athanasios
    Alexiou, Ioannis
    Barouta, Georgia
    Sakkas, Lazaros I.
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
  • [38] Responses to exercise in systemic sclerosis-associated interstitial lung disease
    Donnelly, Ronan P.
    Smyth, Anita E.
    Mullan, Charles
    Riley, Marshall S.
    Nicholls, D. Paul
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2023, 43 (04) : 253 - 262
  • [39] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [40] Systemic sclerosis-associated interstitial lung disease treated with tocilizumab
    Dauny, Vincent
    Borie, Raphael
    Forien, Marine
    Ghanem, Mada
    Palazzo, Elisabeth
    Jelin, Germain
    Dieude, Philippe
    Ottaviani, Sebastien
    INTERNAL MEDICINE JOURNAL, 2021, 51 (06) : 999 - 1000
12345